Published in Health Risk Factor Week, April 24th, 2007
This trend article about Gazi University, Turkey, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Assessment of protein oxidation in women using raloxifene," is the subject of a report. "To assess the oxidative effects of raloxifene use in postmenopausal women by investigating protein carbonyl levels in the plasma. Nineteen osteoporotic postmenopausal women treated with raloxifene for 12 months were included in the study," scientists writing in the journal Molecular and Cellular Biochemistry report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.